About
Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T therapies targeting immune-related pathways for the treatment of oncology and autoimmune diseases.
Explore Tempest Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.